| Id |
Subject |
Object |
Predicate |
Lexical cue |
| TextSentencer_T1 |
0-68 |
Sentence |
denotes |
Poly(ADP-ribosyl)ation in relation to cancer and autoimmune disease. |
| T1 |
0-68 |
Sentence |
denotes |
Poly(ADP-ribosyl)ation in relation to cancer and autoimmune disease. |
| TextSentencer_T2 |
69-171 |
Sentence |
denotes |
Carcinogenesis involves multiple steps and pathways with functional alterations in a variety of genes. |
| T2 |
69-171 |
Sentence |
denotes |
Carcinogenesis involves multiple steps and pathways with functional alterations in a variety of genes. |
| TextSentencer_T3 |
172-383 |
Sentence |
denotes |
There is accumulating evidence that a deficiency of poly(ADP-ribose) polymerase (PARP)-1 leads to DNA repair defects, genomic instability, failure of induction of cell death and modulation of gene transcription. |
| T3 |
172-383 |
Sentence |
denotes |
There is accumulating evidence that a deficiency of poly(ADP-ribose) polymerase (PARP)-1 leads to DNA repair defects, genomic instability, failure of induction of cell death and modulation of gene transcription. |
| TextSentencer_T4 |
384-453 |
Sentence |
denotes |
PARP-1 also supports the growth of tumor cells in certain situations. |
| T4 |
384-453 |
Sentence |
denotes |
PARP-1 also supports the growth of tumor cells in certain situations. |
| TextSentencer_T5 |
454-707 |
Sentence |
denotes |
Genetic analyses of the PARP-1 gene have demonstrated alterations in neoplasms, and a mutation affecting the conserved amino acid E251 in germ cell tumors, as well as an association of a single-nucleotide polymorphism V762A with risk of prostate cancer. |
| T5 |
454-707 |
Sentence |
denotes |
Genetic analyses of the PARP-1 gene have demonstrated alterations in neoplasms, and a mutation affecting the conserved amino acid E251 in germ cell tumors, as well as an association of a single-nucleotide polymorphism V762A with risk of prostate cancer. |
| TextSentencer_T6 |
708-978 |
Sentence |
denotes |
Recent development of a selective inhibitor of poly(ADP-ribose) glycohydrolase (PARG), the enzyme primarily responsible for degradation of poly(ADP-ribose), and PARG-deficient animals should facilitate studies of the relationship of poly(ADP-ribose) with carcinogenesis. |
| T6 |
708-978 |
Sentence |
denotes |
Recent development of a selective inhibitor of poly(ADP-ribose) glycohydrolase (PARG), the enzyme primarily responsible for degradation of poly(ADP-ribose), and PARG-deficient animals should facilitate studies of the relationship of poly(ADP-ribose) with carcinogenesis. |
| TextSentencer_T7 |
979-1148 |
Sentence |
denotes |
Inhibitors of PARP have also suggested roles in the pathogenesis of autoimmune disease, and a promoter haplotype of PARP-1 confers a higher risk of rheumatoid arthritis. |
| T7 |
979-1148 |
Sentence |
denotes |
Inhibitors of PARP have also suggested roles in the pathogenesis of autoimmune disease, and a promoter haplotype of PARP-1 confers a higher risk of rheumatoid arthritis. |
| TextSentencer_T8 |
1149-1296 |
Sentence |
denotes |
Further analysis of PARP-1, PARG and other PARP family genes should extend our understanding of the pathogenesis of cancer and autoimmune diseases. |
| T8 |
1149-1296 |
Sentence |
denotes |
Further analysis of PARP-1, PARG and other PARP family genes should extend our understanding of the pathogenesis of cancer and autoimmune diseases. |
| TextSentencer_T9 |
1297-1482 |
Sentence |
denotes |
Furthermore, there is potential for sensitization to chemo- and radiation therapy of cancers as well as the treatment of autoimmune disease with development of stronger PARP inhibitors. |
| T9 |
1297-1482 |
Sentence |
denotes |
Furthermore, there is potential for sensitization to chemo- and radiation therapy of cancers as well as the treatment of autoimmune disease with development of stronger PARP inhibitors. |